Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04890314 · ClinicalTrials.gov registry record
Prostate Cancer - Comparative Outcomes of New Conceptual Paradigms for Treatment
A clinical trial, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- 1,953
- Enrollment target
NCT04890314: Completed study, sponsored by Weill Medical College of Cornell University.
NCT04890314 is a clinical trial that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 1,953 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04890314 has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- 1,953 participants
- Enrollment target
Study Summary
This study will use a population-based cohort design to study men with newly diagnosed low- and intermediate-risk prostate cancer at high-volume centers in Southern California (SCa) and New York State (NYS). Complications of contemporary treatments for prostate cancer and quality of life outcomes, such as general health, urinary, sexual, and bowel function, cancer anxiety, and treatment regret will be compared and tracked over the course of this study.
Primary Outcome
All adverse events will be graded as an event occurred, event will indicate an adverse event occurred. observations only; intervention not indicated.
Interventions
- OTHER Patient-reported questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,953 participants |
| Start Date | 2021-05-15 |
| Est. Completion | 2024-04-30 |
What the finished NCT04890314 record still lists
NCT04890314 is an observational study that tracks outcomes without assigning an intervention. Its 1,953 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Patient-reported questionnaire is the first listed.
NCT04890314 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04890314 about?
NCT04890314 is a clinical study titled "Prostate Cancer - Comparative Outcomes of New Conceptual Paradigms for Treatment". This study will use a population-based cohort design to study men with newly diagnosed low- and intermediate-risk prostate cancer at high-volume centers in Southern California (SCa) and New York State (NYS). Complications of contemporary treatments for prostate cancer and quality of life outcomes, s...
What is the current status of trial NCT04890314?
This trial is currently completed. The enrollment target is 1,953 participants. The study started on 2021-05-15. Estimated completion is 2024-04-30.
What interventions are being tested in trial NCT04890314?
The interventions under investigation include: Patient-reported questionnaire (OTHER).
Who is sponsoring clinical trial NCT04890314?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04251052 · 1,956 participants · NA
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
- NCT05233150 · 1,932 participants · NA
Child-Adult Relationship Enhancement in Primary Care (PriCARE) / Criando Niños Con CARIÑO (CARIÑO)
- NCT06062394 · 1,980 participants · NA
Penn Medicine Healthy Heart
- NCT07321886 · 1,980 participants · Phase 3
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI